Literature DB >> 27609978

Specific immune cell and cytokine characteristics of human testicular germ cell neoplasia.

Britta Klein1, Thomas Haggeney2, Daniela Fietz2, Sivanjah Indumathy3, Kate L Loveland4, Mark Hedger3, Sabine Kliesch5, Wolfgang Weidner6, Martin Bergmann2, Hans-Christian Schuppe6.   

Abstract

STUDY QUESTION: Which immune cells and cytokine profiles are characteristic for testicular germ cell neoplasia and what consequences does this have for the understanding of the related testicular immunopathology? SUMMARY ANSWER: The unique immune environment of testicular germ cell neoplasia comprises B cells and dendritic cells as well as high transcript levels of IL-6 and other B cell supporting or T helper cell type 1 (Th1)-driven cytokines and thus differs profoundly from normal testis or inflammatory lesions associated with hypospermatogenesis. WHAT IS KNOWN ALREADY: T cells are known to be the major component of inflammatory infiltrates associated with either hypospermatogenesis or testicular cancer. It has previously been reported that B cells are only involved within infiltrates of seminoma samples, but this has not been investigated further. STUDY DESIGN, SIZE, DURATION: Immunohistochemical characterisation (IHC) of infiltrating immune cells and RT-qPCR-based analysis of corresponding cytokine microenvironments was performed on different testicular pathologies. Testicular biopsies, obtained from men undergoing andrological work-up of infertility or taken during surgery for testicular cancer, were used in this study. Samples were grouped as follows: (i) normal spermatogenesis (n = 18), (ii) hypospermatogenesis associated with lymphocytic infiltrates (n = 10), (iii) samples showing neoplasia [germ cell neoplasia in situ (GCNIS, n = 26) and seminoma, n = 18]. PARTICIPANTS/MATERIALS, SETTING,
METHODS: IHC was performed using antibodies against T cells (CD3+), B cells (CD20cy+), dendritic cells (CD11c+), macrophages (CD68+) and mast cells (mast cell tryptase+). Degree and compartmental localisation of immune cells throughout all groups analysed was evaluated semi-quantitatively. RT-qPCR on RNA extracted from cryo-preserved tissue samples was performed to analyse mRNA cytokine expression, specifically levels of IL-1β, IL-6, IL-17a, tumour necrosis factor (TNF)-α (pro-inflammatory), IL-10, transforming growth factor (TGF)-β1 (anti-inflammatory), IL-2, IL-12a, IL-12b, interferon (IFN)-γ (Th1-driven), IL-4, IL-5, IL-13, IL-23a (Th2-driven), CXCL-13, CXCL-10 and CCL-5 (chemokines). MAIN RESULTS AND THE ROLE OF CHANCE: This is the first study showing a direct linkage between the distribution pattern of immune cells in hypospermatogenesis versus testicular cancer and analysis of a wide range of 17 related cyto- and chemokines. A fundamental difference between testicular inflammation patterns associated with different testicular inflammatory conditions either containing or lacking neoplastic cells was demonstrated. In hypospermatogenesis, T cells were detected, whereas B cells and dendritic cells were almost absent. Within GCNIS and seminoma, in addition to T cells, high numbers of dendritic cells and B cells were found, the latter additionally organised in cell clusters, whereas mast cells were absent. Transcripts encoding pro-inflammatory cytokines (IL-1β, IL-6 and TNF-α), anti-inflammatory cytokines (TGF-β1), Th1-driven cytokines (IL-2 and IFN-γ) as well as chemokines (CXCL-13, CXCL-10 and CCL-5) were all significantly increased in testicular germ cell neoplasia (P ≤ 0.01), suggesting the presence of a pro-tumorigenic environment. In contrast, Th2-related cytokines (IL-5, IL-13 and IL-23a) characterised the environment within samples showing normal spermatogenesis as well as hypospermatogenesis. One of the most important outcomes is the pivotal role of IL-6 in testicular cancer that opens potential novel diagnostic and/or immune-therapeutic perspective for testis cancer. LIMITATIONS, REASONS FOR CAUTION: Testicular tissue composed of immune cells as well as other somatic cells and germ cells does not allow identification of specific cytokine sources or single cell types, being responsible for establishing the overall cytokine environment. In this study, laser-assisted microdissection did not reach the required efficiency for RT-qPCR analyses. Therefore, in vitro models would be suggested for addressing the above-mentioned issue. Conclusions about cytokine levels in testes with GCNIS are based on a small number of samples. WIDER IMPLICATIONS OF THE
FINDINGS: The unique B cell presence and the significantly increased expression level of IL-6 in testicular germ cell neoplasia (P < 0.001) strengthen its special role in this disease. In line with current knowledge on other types of cancer, these results underline the relevance of further investigating the potential of IL-6 as early biomarker and target for therapeutic intervention in testicular germ cell neoplasia. STUDY FUNDING/COMPETING INTERESTS: This study (and B.K. in person) was supported by the Deutsche Forschungsgemeinschaft (DFG) as part of the International Research Training Group between Justus Liebig University of Giessen and Monash University, Melbourne (GRK 1871/1) on 'Molecular pathogenesis on male reproductive disorders'. T.H., H.-C.S. and M.B. were supported by the LOEWE focus group 'MIBIE' (male infertility during infection &amp; inflammation)-an excellence initiative of the German state government of Hessen. From the Australian side, K.L. was supported by NHMRC grants (Fellowship, ID1079646 and Project, ID1081987); K.L., S.I. and M.H. received scholarship (S.I.) and research funding (K.L., M.H.) from Monash University. The project also drew support from the Victorian Government's Operational Infrastructure Support Program. The authors have no competing interests to declare.
© The Author 2016. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  RT-qPCR; TIL; cytokines; germ cell neoplasia in situ (GCNIS); immune cell; inflammation; testicular germ cell tumour; testis; tumour environment

Mesh:

Substances:

Year:  2016        PMID: 27609978     DOI: 10.1093/humrep/dew211

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  26 in total

1.  Differentiation of Human Wharton Jelly Mesenchymal Stem Cells into Germ-Like Cells; emphasis on evaluation of Germ-long non-coding RNAs.

Authors:  Samira Ghasemi; Mohammad Shafiee; Gordon A Ferns; Jalil Tavakol-Afshari; Mohsen Saeedi; Sara Raji; Naser Mobarra
Journal:  Mol Biol Rep       Date:  2022-10-15       Impact factor: 2.742

2.  Biological functions of RNA modification patterns that define tumor microenvironment and survival outcomes in testicular germ cell tumors.

Authors:  Weijun Tang; Jinke Qian; Shilei Qian
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

Review 3.  Hypertension and reproductive dysfunction: a possible role of inflammation and inflammation-associated lymphangiogenesis in gonads.

Authors:  Shobana Navaneethabalakrishnan; Bethany L Goodlett; Alexandra H Lopez; Joseph M Rutkowski; Brett M Mitchell
Journal:  Clin Sci (Lond)       Date:  2020-12-23       Impact factor: 6.876

4.  Brentuximab vedotin exerts profound antiproliferative and pro-apoptotic efficacy in CD30-positive as well as cocultured CD30-negative germ cell tumour cell lines.

Authors:  Stefan Schönberger; Cornelius van Beekum; Barbara Götz; Daniel Nettersheim; Hubert Schorle; Dominik T Schneider; Anna Casati; Rogerio B Craveiro; Gabriele Calaminus; Dagmar Dilloo
Journal:  J Cell Mol Med       Date:  2017-09-22       Impact factor: 5.310

Review 5.  Cytokines in Male Fertility and Reproductive Pathologies: Immunoregulation and Beyond.

Authors:  Kate L Loveland; Britta Klein; Dana Pueschl; Sivanjah Indumathy; Martin Bergmann; Bruce E Loveland; Mark P Hedger; Hans-Christian Schuppe
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-20       Impact factor: 5.555

6.  Testicular activin and follistatin levels are elevated during the course of experimental autoimmune epididymo-orchitis in mice.

Authors:  Nour Nicolas; Vera Michel; Sudhanshu Bhushan; Eva Wahle; Susan Hayward; Helen Ludlow; David M de Kretser; Kate L Loveland; Hans-Christian Schuppe; Andreas Meinhardt; Mark P Hedger; Monika Fijak
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

7.  Serum biomarkers to predict risk of testicular and penile cancer in AMORIS.

Authors:  Arunangshu Ghoshal; Hans Garmo; Rhonda Arthur; Niklas Hammar; Ingmar Jungner; Håkan Malmström; Mats Lambe; Göran Walldius; Mieke Van Hemelrijck
Journal:  Ecancermedicalscience       Date:  2017-08-23

Review 8.  Immune-Related Concepts in Biology and Treatment of Germ-Cell Tumors.

Authors:  Michal Chovanec; Ugo De Giorgi; Michal Mego
Journal:  Adv Urol       Date:  2018-03-13

Review 9.  Infectious, inflammatory and 'autoimmune' male factor infertility: how do rodent models inform clinical practice?

Authors:  Monika Fijak; Adrian Pilatz; Mark P Hedger; Nour Nicolas; Sudhanshu Bhushan; Vera Michel; Kenneth S K Tung; Hans-Christian Schuppe; Andreas Meinhardt
Journal:  Hum Reprod Update       Date:  2018-07-01       Impact factor: 15.610

Review 10.  The 12-CK Score: Global Measurement of Tertiary Lymphoid Structures.

Authors:  Roger Li; Anders Berglund; Logan Zemp; Jasreman Dhillon; Ryan Putney; Youngchul Kim; Rohit K Jain; G Daniel Grass; José Conejo-Garcia; James J Mulé
Journal:  Front Immunol       Date:  2021-06-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.